Thioacetamide-induced Fulminant Hepatic Failure Induces Cerebral Mitochondrial Dysfunction by Altering the Electron Transport Chain Complexes
Overview
Affiliations
Fulminant hepatic failure (FHF) is an acute form of hepatic encephalopathy resulting from severe inflammatory or necrotic liver damage without any previously established liver damage. This develops as a complication due to viral infections, and drug abuse. FHF also occurs in acute disorders like Reye's syndrome. Although the exact mechanisms in the etiology of FHF are not understood, elevated levels of brain ammonia have been consistently reported. Such increased ammonia levels are suggested to alter neurotransmission signals and impair cerebral energy metabolism due to mitochondrial dysfunctions. In the present study we have examined the role of cerebral electron transport chain complexes, including complex I, II, III IV, and pyruvate dehydrogenase in the non-synaptic mitochondria isolated from the cortex of the thioacetamide-induced FHF rats. Further, we have examined if the structure of mitochondria is altered. The results of the current study demonstrated a decrease in the activity of the complex I by 31 and 48% at 18 and 24 h respectively after the thioacetamide injection. Similarly, the activity of electron transport chain complex III was inhibited by 35 and 52% respectively, at 18 and 24 h, respectively. The complex II and complex IV, on the other hand, revealed unaltered activity. Further the activity of pyruvate dehydrogenase at 18 and 24 h after the induction of FHF was inhibited by 29 and 43%, respectively. Our results also suggest mitochondrial swelling in FHF induced rats. The inhibition of the respiratory complexes III and I and pyruvate dehydrogenase might lead to the increased production of free radical resulting in oxidative stress and cerebral energy disturbances thereby leading to mitochondrial swelling and further contributing to the pathogenesis of FHF.
Niknahad H, Mobasheri A, Arjmand A, Rafiei E, Alidaee S, Razavi H Heliyon. 2023; 9(10):e20557.
PMID: 37810869 PMC: 10551565. DOI: 10.1016/j.heliyon.2023.e20557.
Ayoub I, El-Baset M, Elghonemy M, Bashandy S, Ibrahim F, Ahmed-Farid O Molecules. 2022; 27(19).
PMID: 36235007 PMC: 9573427. DOI: 10.3390/molecules27196470.
Dysregulation of Astrocytic Glutamine Transport in Acute Hyperammonemic Brain Edema.
Zielinska M, Albrecht J, Popek M Front Neurosci. 2022; 16:874750.
PMID: 35733937 PMC: 9207324. DOI: 10.3389/fnins.2022.874750.
The regulatory role of PGC1α-related coactivator in response to drug-induced liver injury.
Buler M, Naessens T, Mattsson J, Morias Y, Soderberg M, Robbins P FASEB Bioadv. 2020; 2(8):453-463.
PMID: 32821877 PMC: 7429352. DOI: 10.1096/fba.2020-00003.
Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy.
Dhanda S, Sunkaria A, Halder A, Sandhir R Metab Brain Dis. 2017; 33(1):209-223.
PMID: 29138968 DOI: 10.1007/s11011-017-0136-8.